1. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., and Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond) 332: 411–415.
2. Vierhapper, H., Wagner, O., Nowotny, P., and Waldhausl, W. (1990) Effect of endothelin-1 in man. Circulation
81: 1415–1418.
3. Sorensen, S. S., Madsen, J. K., and Pedersen, E. B. (1994) Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. Am. J. Physiol 266: F411 — F418.
4. Rabelink, T. J., Kaasiager, K. A. H., Boer, P., Stroes, E. G., Braam, B., and Koomans, H. A. (1994) Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology. Kidney Int. 46: 376–381.
5. Yokokawa, K., Tahara, H., Kohno, M., Murakawa, K., Yasunari, K., Nakagawa, K., Hamada, T., Otani, S., Yanagisawa, M., and Takeda, T. (1991) Hypertension associated with endothelin-secreting malignant hemangioendothelioma. Ann. Intern. Med. 114:213–215.